Abstract: The invention includes a patch and method for transdermal delivery of bupropion base. In the method of this invention, a patient is administered a bupropion base in an amount effective to alleviate withdrawal symptoms and to prevent or reduce craving of nicotine in said patient. Alternatively, an effective amount of bupropion base is delivered to alleviate depression in a patient or to treat obesity. A transdermal patch includes a bupropion base. The bupropion base can be mixed with an acceptable pharmaceutical carrier.
Type:
Grant
Filed:
May 2, 2000
Date of Patent:
November 6, 2001
Assignee:
Peierce Management LLC
Inventors:
Kamal K. Midha, Hans E. Junginger, Mark Hirsh